Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm2 of the face or scalp in patients with actinic keratosis: A phase 3 studyCapsule Summary by Neal Bhatia, MD, Edward Lain, MD, Abel Jarell, MD, Janet DuBois, MD, Maria Luisa Tamarit, MD, Meritxell Falques, MSc, Vera Kiyasova, MD, PhD, Laura Padullés, PhD, Raquel Otero, PhD, Andrew Blauvelt, MD, MBA

Connect to this object online.